Holen Sie sich die Stockscreener-App
77.40
1.83%
1.39
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NFLX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$76.01
Offen:
$76.64
24-Stunden-Volumen:
22.18M
Relative Volume:
0.55
Marktkapitalisierung:
$322.29B
Einnahmen:
$48.77B
Nettoeinkommen (Verlust:
$13.65B
KGV:
24.38
EPS:
3.1742
Netto-Cashflow:
$11.15B
1W Leistung:
-1.09%
1M Leistung:
+3.49%
6M Leistung:
-18.43%
1J Leistung:
-35.69%
1-Tages-Spanne:
$76.15
$77.57
1-Wochen-Bereich:
$75.03
$77.73
52-Wochen-Spanne:
$65.08
$124.86
Netflix Inc Stock (NFLX) Company Profile
Firmenname
Netflix Inc
Sektor
Branche
Telefon
408-540-3700
Adresse
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, WBD, LYV, FOXA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
77.40 | 322.29B | 48.77B | 13.65B | 11.15B | 3.1742 |
DIS
Walt Disney Co
|
106.55 | 183.98B | 97.37B | 12.34B | 7.11B | 6.2499 |
WBD
Warner Bros Discovery Inc
|
28.04 | 70.30B | 37.25B | -1.71B | 2.31B | -0.6988 |
LYV
Live Nation Entertainment Inc
|
170.15 | 39.64B | 25.61B | -229.57M | 1.21B | -1.7628 |
FOXA
Fox Corp
|
65.94 | 27.72B | 16.20B | 1.75B | 2.14B | 3.789 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Herabstufung | Erste Group | Buy → Hold |
| 2026-04-20 | Bestätigt | Bernstein | Outperform |
| 2026-04-06 | Hochstufung | Goldman | Neutral → Buy |
| 2026-03-30 | Eingeleitet | Citizens | Mkt Perform |
| 2026-03-24 | Hochstufung | Erste Group | Hold → Buy |
| 2026-03-18 | Fortgesetzt | Citigroup | Buy |
| 2026-03-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2026-03-02 | Fortgesetzt | Barclays | Equal Weight |
| 2026-03-02 | Fortgesetzt | JP Morgan | Overweight |
| 2026-02-27 | Hochstufung | Arete | Neutral → Buy |
| 2026-02-27 | Fortgesetzt | Evercore ISI | Outperform |
| 2026-01-23 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-21 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-01-21 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2026-01-21 | Bestätigt | Goldman | Neutral |
| 2026-01-21 | Bestätigt | Guggenheim | Buy |
| 2026-01-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-21 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-21 | Bestätigt | Needham | Buy |
| 2026-01-21 | Bestätigt | Oppenheimer | Outperform |
| 2026-01-21 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-21 | Bestätigt | Pivotal Research Group | Hold |
| 2026-01-21 | Bestätigt | Rosenblatt | Neutral |
| 2026-01-21 | Bestätigt | Rothschild & Co Redburn | Buy |
| 2026-01-21 | Bestätigt | TD Cowen | Buy |
| 2026-01-21 | Bestätigt | UBS | Buy |
| 2026-01-21 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-12 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-09 | Bestätigt | Goldman | Neutral |
| 2025-12-08 | Herabstufung | Pivotal Research Group | Buy → Hold |
| 2025-12-08 | Herabstufung | Rosenblatt | Buy → Neutral |
| 2025-11-18 | Bestätigt | Barclays | Equal Weight |
| 2025-10-31 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-07 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2025-09-17 | Hochstufung | Loop Capital | Hold → Buy |
| 2025-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-07 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2025-07-02 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-02 | Bestätigt | Goldman | Neutral |
| 2025-06-20 | Bestätigt | Pivotal Research Group | Buy |
| 2025-06-12 | Bestätigt | Oppenheimer | Outperform |
| 2025-06-03 | Bestätigt | Jefferies | Buy |
| 2025-05-30 | Bestätigt | BofA Securities | Buy |
| 2025-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-21 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-04-21 | Bestätigt | Barclays | Equal Weight |
| 2025-04-21 | Bestätigt | Canaccord Genuity | Buy |
| 2025-04-21 | Bestätigt | Guggenheim | Buy |
| 2025-04-21 | Bestätigt | JP Morgan | Overweight |
| 2025-04-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-04-21 | Bestätigt | MoffettNathanson | Buy |
| 2025-04-21 | Bestätigt | Morgan Stanley | Overweight |
| 2025-04-21 | Bestätigt | Oppenheimer | Outperform |
| 2025-04-21 | Bestätigt | Piper Sandler | Overweight |
| 2025-04-21 | Bestätigt | Pivotal Research Group | Buy |
| 2025-04-21 | Bestätigt | Wells Fargo | Overweight |
| 2025-04-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-03-27 | Eingeleitet | FBN Securities | Outperform |
| 2025-03-17 | Hochstufung | MoffettNathanson | Neutral → Buy |
| 2025-01-24 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-01-22 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2025-01-22 | Bestätigt | Oppenheimer | Outperform |
| 2025-01-22 | Bestätigt | Pivotal Research Group | Buy |
| 2025-01-22 | Hochstufung | Rosenblatt | Neutral → Buy |
| 2025-01-22 | Hochstufung | The Benchmark Company | Sell → Hold |
| 2025-01-16 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2025-01-15 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-01-15 | Bestätigt | Oppenheimer | Outperform |
| 2025-01-08 | Bestätigt | Goldman | Neutral |
| 2025-01-06 | Bestätigt | Argus | Buy |
| 2025-01-03 | Bestätigt | The Benchmark Company | Sell |
| 2024-12-19 | Bestätigt | UBS | Buy |
| 2024-12-16 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-12-16 | Bestätigt | Oppenheimer | Outperform |
| 2024-12-11 | Bestätigt | JP Morgan | Overweight |
| 2024-11-20 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-18 | Bestätigt | Needham | Buy |
| 2024-10-18 | Bestätigt | Oppenheimer | Outperform |
| 2024-10-18 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-16 | Bestätigt | Loop Capital | Buy |
| 2024-10-11 | Bestätigt | Guggenheim | Buy |
| 2024-10-10 | Bestätigt | Morgan Stanley | Overweight |
| 2024-10-10 | Bestätigt | Oppenheimer | Outperform |
| 2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-10-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-10-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-09-05 | Eingeleitet | China Renaissance | Hold |
| 2024-08-30 | Bestätigt | Pivotal Research Group | Buy |
| 2024-07-17 | Bestätigt | Guggenheim | Buy |
| 2024-07-16 | Bestätigt | The Benchmark Company | Sell |
| 2024-07-15 | Bestätigt | BofA Securities | Buy |
| 2024-07-12 | Bestätigt | JP Morgan | Overweight |
| 2024-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-07-09 | Bestätigt | TD Cowen | Buy |
| 2024-07-02 | Bestätigt | Argus | Buy |
| 2024-05-28 | Bestätigt | Evercore ISI | Outperform |
| 2024-04-19 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-04-19 | Hochstufung | Needham | Hold → Buy |
| 2024-04-19 | Bestätigt | Pivotal Research Group | Buy |
| 2024-04-15 | Bestätigt | Deutsche Bank | Hold |
| 2024-04-12 | Bestätigt | Morgan Stanley | Overweight |
| 2024-04-12 | Bestätigt | Piper Sandler | Neutral |
| 2024-04-05 | Bestätigt | Pivotal Research Group | Buy |
| 2024-03-25 | Bestätigt | Citigroup | Neutral |
| 2024-03-12 | Bestätigt | Jefferies | Buy |
| 2024-03-11 | Bestätigt | Oppenheimer | Outperform |
| 2024-01-30 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2024-01-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2024-01-24 | Bestätigt | BMO Capital Markets | Outperform |
| 2024-01-24 | Bestätigt | BofA Securities | Buy |
| 2024-01-24 | Bestätigt | Canaccord Genuity | Buy |
| 2024-01-24 | Bestätigt | Evercore ISI | Outperform |
| 2024-01-24 | Bestätigt | Goldman | Neutral |
| 2024-01-24 | Bestätigt | Guggenheim | Buy |
| 2024-01-24 | Bestätigt | JP Morgan | Overweight |
| 2024-01-24 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-01-24 | Hochstufung | Macquarie | Neutral → Outperform |
| 2024-01-24 | Bestätigt | Morgan Stanley | Overweight |
| 2024-01-24 | Bestätigt | Oppenheimer | Outperform |
| 2024-01-24 | Bestätigt | Piper Sandler | Neutral |
| 2024-01-24 | Bestätigt | Pivotal Research Group | Buy |
| 2024-01-24 | Bestätigt | Redburn Atlantic | Buy |
| 2024-01-24 | Bestätigt | Robert W. Baird | Outperform |
| 2024-01-24 | Bestätigt | TD Cowen | Outperform |
| 2024-01-24 | Bestätigt | UBS | Buy |
| 2024-01-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-09-18 | Bestätigt | Evercore ISI | Outperform |
| 2023-08-25 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-07-17 | Bestätigt | Deutsche Bank | Buy |
| 2023-07-13 | Bestätigt | JP Morgan | Overweight |
| 2023-07-12 | Bestätigt | UBS | Buy |
| 2023-07-05 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-29 | Bestätigt | Citigroup | Buy |
| 2023-06-28 | Bestätigt | Oppenheimer | Outperform |
| 2023-06-13 | Bestätigt | BofA Securities | Buy |
| 2023-06-13 | Bestätigt | Guggenheim | Buy |
| 2023-04-19 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Jefferies | Buy |
| 2023-04-19 | Bestätigt | Piper Sandler | Neutral |
| 2023-04-19 | Bestätigt | Pivotal Research Group | Buy |
| 2023-04-19 | Bestätigt | Rosenblatt | Neutral |
| 2023-04-19 | Hochstufung | UBS | Neutral → Buy |
| 2023-04-11 | Fortgesetzt | Robert W. Baird | Neutral |
| 2023-01-23 | Bestätigt | Argus | Buy |
| 2023-01-20 | Bestätigt | Canaccord Genuity | Buy |
| 2023-01-20 | Bestätigt | Deutsche Bank | Buy |
| 2023-01-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-01-20 | Bestätigt | Goldman | Sell |
| 2023-01-20 | Bestätigt | Guggenheim | Buy |
| 2023-01-20 | Bestätigt | Jefferies | Buy |
| 2023-01-20 | Bestätigt | MoffettNathanson | Market Perform |
| 2023-01-20 | Bestätigt | Oppenheimer | Outperform |
| 2023-01-20 | Bestätigt | Piper Sandler | Neutral |
| 2023-01-20 | Bestätigt | Pivotal Research Group | Buy |
| 2023-01-20 | Bestätigt | Robert W. Baird | Neutral |
| 2023-01-20 | Bestätigt | The Benchmark Company | Sell |
| 2023-01-20 | Bestätigt | Wedbush | Outperform |
| 2023-01-20 | Bestätigt | Wolfe Research | Outperform |
| 2023-01-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-04 | Eingeleitet | New Street | Neutral |
| 2022-12-29 | Hochstufung | CFRA | Sell → Buy |
| 2022-12-14 | Bestätigt | Jefferies | Hold |
| 2022-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-06-14 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-06-10 | Herabstufung | Goldman | Neutral → Sell |
| 2022-05-16 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-04-21 | Herabstufung | DZ Bank | Buy → Hold |
| 2022-04-21 | Herabstufung | Edward Jones | Buy → Hold |
| 2022-04-20 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-20 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-04-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-20 | Hochstufung | Needham | Underperform → Hold |
| 2022-04-20 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | Pivotal Research Group | Buy → Sell |
| 2022-04-20 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-20 | Herabstufung | UBS | Buy → Neutral |
| 2022-04-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
| 2022-03-09 | Hochstufung | Wedbush | Underperform → Neutral |
| 2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-31 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-01-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-21 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-01-21 | Bestätigt | BofA Securities | Buy |
| 2022-01-21 | Bestätigt | Canaccord Genuity | Buy |
| 2022-01-21 | Bestätigt | Cowen | Outperform |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Goldman | Neutral |
| 2022-01-21 | Bestätigt | Guggenheim | Buy |
| 2022-01-21 | Bestätigt | JP Morgan | Overweight |
| 2022-01-21 | Bestätigt | MoffettNathanson | Neutral |
| 2022-01-21 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-01-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-21 | Bestätigt | Oppenheimer | Outperform |
| 2022-01-21 | Bestätigt | Piper Sandler | Overweight |
| 2022-01-21 | Bestätigt | Pivotal Research Group | Buy |
| 2022-01-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Hochstufung | The Benchmark Company | Sell → Hold |
| 2022-01-21 | Herabstufung | Truist | Buy → Hold |
| 2022-01-21 | Bestätigt | UBS | Buy |
| 2022-01-21 | Bestätigt | Wolfe Research | Outperform |
| 2021-12-15 | Bestätigt | The Benchmark Company | Sell |
| 2021-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-10-20 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-09-29 | Bestätigt | The Benchmark Company | Sell |
| 2021-09-13 | Eingeleitet | Goldman | Neutral |
| 2021-09-08 | Bestätigt | JP Morgan | Overweight |
| 2021-09-07 | Bestätigt | Atlantic Equities | Overweight |
| 2021-07-21 | Bestätigt | Credit Suisse | Outperform |
| 2021-07-21 | Bestätigt | Deutsche Bank | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-06-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-06-25 | Eingeleitet | Edward Jones | Hold |
| 2021-05-19 | Fortgesetzt | Jefferies | Buy |
| 2021-04-21 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-21 | Bestätigt | Pivotal Research Group | Buy |
| 2021-04-21 | Hochstufung | Stifel | Hold → Buy |
| 2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-04-01 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-25 | Bestätigt | The Benchmark Company | Sell |
| 2021-03-23 | Hochstufung | Argus | Hold → Buy |
| 2021-01-21 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-01-20 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-01-20 | Bestätigt | Pivotal Research Group | Buy |
| 2021-01-20 | Bestätigt | The Benchmark Company | Sell |
| 2021-01-20 | Hochstufung | UBS | Neutral → Buy |
| 2021-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-10-21 | Bestätigt | BMO Capital Markets | Outperform |
| 2020-10-21 | Bestätigt | Bernstein | Outperform |
| 2020-10-21 | Bestätigt | Jefferies | Buy |
| 2020-10-21 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-21 | Bestätigt | Oppenheimer | Outperform |
| 2020-10-21 | Bestätigt | Piper Sandler | Overweight |
| 2020-10-21 | Bestätigt | Pivotal Research Group | Buy |
| 2020-10-21 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-21 | Bestätigt | The Benchmark Company | Sell |
| 2020-10-21 | Bestätigt | Wedbush | Underperform |
| 2020-10-21 | Bestätigt | Wells Fargo | Equal Weight |
| 2020-10-16 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-15 | Bestätigt | Canaccord Genuity | Buy |
| 2020-10-14 | Bestätigt | Goldman | Buy |
| 2020-10-07 | Bestätigt | Pivotal Research Group | Buy |
| 2020-09-28 | Bestätigt | The Benchmark Company | Sell |
| 2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-09 | Fortgesetzt | Raymond James | Mkt Perform |
| 2020-09-04 | Bestätigt | The Benchmark Company | Sell |
| 2020-07-29 | Bestätigt | Loop Capital | Buy |
Alle ansehen
Netflix Inc Aktie (NFLX) Neueste Nachrichten
Sen. Cory A. Booker Sells Off Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. $NFLX Shares Bought by Corient Private Wealth LP - MarketBeat
Amy Ryan plays the fentanyl nurse at the heart of Netflix’s Yale drama ‘The Retrievals’ - IMDb
Do You Need To Watch The Gentlemen Movie Before The Netflix Series? - IMDb
Florida Sues Netflix for Billions, Alleging It Secretly Harvested Kids’ Data to Fuel Ads - Law Commentary
God’s Not Dead’s Kevin Sorbo Calls Out Netflix as ‘Sick’ Following ‘Neck Injury’ Post - Yahoo
Minka Kelly Responds to ‘Ransom Canyon’ Cancellation at Netflix After Two Seasons: “All Good Things Must Come to an End” - IMDb
‘Evil Genius’: Why Courteney Cox Turned the Netflix True Crime Doc Into a ‘Twisted Comedy’ Movie - IMDb
Netflix (NASDAQ:NFLX) Stock Price Up 1.8%Should You Buy? - MarketBeat
What to Watch on Netflix: September 11, 2026 | Physical 100: Italy to Jo Koy: Blue in the Face - IMDb
Netflix hit with major lawsuit over alleged secret tracking of families and children - Fast Company
Netflix Subscribers Are Begging Company to Undo Popular TV Show’s Season 3 Cancellation - Yahoo
‘Ransom Canyon’ Canceled After Two Seasons at Netflix - IMDb
Netflix Goes Down Under With NBC Sports, NEP for NFL From Melbourne - Sports Video Group
Five options for streaming on the couch this weekend - Colorado Springs Gazette
‘La Bola Negra’ in Theaters: When You Can See Netflix Cannes Sensation - IMDb
HGTV’s Christina Haack Throws Subtle Shade at Alix Earle’s Netflix Show - IMDb
Florida sues Netflix for secretly tracking kids for ads, risking its growing ad business. - Pluang
Yes, The Gentlemen season 3 is happening despite season 2 viewership decline - netflixlife.com
🏈 Y! Sports Biz: From doubt to Down Under - Yahoo Sports
Netflix drops new trailer for 'Below' starring Josh Hartnett as a fisherman fighting a sea creature - Fox News
Netflix Said It Was Different From Facebook. A New Lawsuit Says It Tracked Kids for Ads Anyway. - Yahoo Finance
MAGA Accuses Netflix of Making an Insensitive “Neck Injury” Post on the Anniversary of Charlie Kirk’s Death - thoughtcatalog.com
Netflix stock slips from 52-week high as insider sells shares - ad-hoc-news.de
Florida AG James Uthmeier sues Netflix over kids' data privacy - qz.com
Do Options Traders Know Something About Netflix Stock We Don't? - Yahoo Finance
Florida sues Netflix, alleging it built its ad business on families’ data - thenextweb.com
Why is Netflix (NASDAQ:NFLX) stock in focus today? - Kalkine Media
Meet the Netflix executive who helps decide what 325 million people watch next - Los Angeles Times
The Manufacturers Life Insurance Company Has $234.61 Million Holdings in Netflix, Inc. $NFLX - MarketBeat
IPG Investment Advisors LLC Sells 15,452 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix Taps ‘Friday Night Lights’ Director Peter Berg for NFL Gameday Openers, the First Narrated by Kyle Chandler - IMDb
Netflix Accused of Celebrating Charlie Kirk’s Death, Company Issues Denial - Newsweek
Go Team! on Netflix turns a company retreat into a scramble to survive the layoffs - Martin Cid Magazine
10 Best British Drama Hidden Gems on Netflix to Watch Right Now - IMDb
Netflix stock heads into the open after a 0.03 percent slip. - ad-hoc-news.de
‘Ransom Canyon’ Canceled by Netflix After 2 Seasons - IMDb
Netflix Will Finally Reveal Box Office Numbers for NARNIA and More - Movieguide
Ransom Canyon Canceled After Two Seasons At Netflix - IMDb
Richard Barton Sells 720 Shares of Netflix (NASDAQ:NFLX) Stock - MarketBeat
What Is NFLX? Netflix Stock’s 6.2× Sales Valuation, Explained - TechStock²
Netflix director Richard Barton sells $109,101 in company stock By Investing.com - Investing.com Canada
What is NFLX? It’s Netflix’s Nasdaq ticker for the streaming company - eciks.org
‘Nobody Wants This’ Season 3 Sets Netflix Release Date, First Images Show Erin Foster, Sarah Silverman and Andrew Rannells’ Roles - IMDb
Netflix Prices in 2026: $8.99 vs. $19.99 vs. $26.99—and the NFLX Stock Math - TechStock²
Netflix (NASDAQ: NFLX) director sells 1,440 shares under preset plan - Stock Titan
Netflix's New 8-Part Gilmore Girls Meets Off Campus Debuts To Rare Rotten Tomatoes Score - IMDb
Florida sues Netflix over misleading parents over minors’ data collection - The Guardian
Florida Attorney General James Uthmeier Files Suit Against Netflix In Tech Crackdown - NorthEscambia.com
Netflix will begin streaming live NFL games tonight—what sport fans should know - Yahoo Sports
Netflix (NASDAQ: NFLX) director lines up another stock sale - Stock Titan
Finanzdaten der Netflix Inc-Aktie (NFLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):